Indi Molecular Appoints Dr. Michael T. Klimas as Senior VP Strategy & Technical Business Development CULVER CITY, Calif., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Indi Molecular, an emerging life sciences company, announced today that it has appointed Michael T. Klimas Ph.D. as senior vice president of...

Indi Molecular Appoints Stephen Worsley Senior VP Business Development CULVER CITY, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Indi Molecular, an emerging life sciences company, announced today that it has appointed Stephen Worsley as senior vice president business...

Indi Molecular Raises $11.5M Series A to Accelerate PCC Platform Development CULVER CITY, CA--(Marketwired - Jun 29, 2017) - Indi Molecular, an emerging life sciences company that is developing a novel, synthetic class of binders with antibody-like properties called protein...

Landmark Indi Molecular(R) Publication in Nature Chemistry Suggests PCC Binding Technology May Enable Therapeutics for Previously Undruggable Targets Based on Mutations of a Single Amino Acid CULVER CITY, CA--(Marketwired - Apr 13, 2015) - Researchers at Caltech and Indi Molecular announced today a landmark publication in Nature Chemistry suggesting that the PCC (protein catalyzed...